Positive circulating tumor cell enrichment method

Abstract

The invention relates to a positive circulating tumor cell enrichment method. The positive circulating tumor cell enrichment method comprises the following steps that S1, a buffer solution and a tumorpatient blood sample are sequentially added in a cell separation solution, and first-time centrifugal treatment is performed; S2, the tumor patient blood sample obtained after the first-time centrifugal treatment is subjected to second-time centrifugal treatment, supernate is removed, red blood cell lysate is added, and then low-temperature splitting decomposition is performed; S3, the tumor patient blood sample obtained in the step S2 is subjected to third-time centrifugal treatment, supernate is removed, incubation liquid is added, then immunomagnetic beads are added, incubation is performed after even mixing, and the immunomagnetic beads are coupled with epithelial cell adhesion molecules; S4, the incubation liquid is removed after incubation, and elution is performed to obtain a target; S5, the target obtained in the step S4 is transferred to a complete culture medium, and continuous culture is performed to obtain circulating tumor cells. The positive circulating tumor cell enrichment method has the advantages of being accurate in capture, capable of keeping cell viability to the most degree, low in cost and efficient.

Description

technical field [0001] The invention relates to in vitro diagnostic technology, in particular to a positive enrichment method for circulating tumor cells. Background technique [0002] Circulating Tumor Cells (CTC, Circulating Tumor Cell) is a general term for various tumor cells existing in peripheral blood. Due to spontaneous or therapeutic operations, they fall off from solid tumor lesions (primary tumors, metastases), and most of the CTCs enter the peripheral blood. After apoptosis or phagocytosis, a few can escape and anchor to develop into metastases, increasing the risk of death in patients with malignant tumors. [0003] It is well known that tumor metastasis is the most important cause of death in cancer patients. According to statistics, 90% of tumor-related deaths are due to tumor metastasis caused by tumor cell invasion and shedding into the blood. Therefore, CTC has always attracted great interest of many oncology experts. Circulating tumor cells (CTCs) that ...

AI Technical Summary

Problems solved by technology

However, the extrusion of the microstructure in the microchannel, the flow field of the high shear flow, the external electric field, and the acoustic field will cause certain damage to the activity of the cells, which will cause trouble for subsequent analysis.

[0011] In summary, although several CTC isolation methods have their own unique detection advantages, there are still some problems exposed, which affect the detection accuracy, sensitivity and specificity of tumor cells.

Moreover, most isolation methods cannot obtain active CTCs for subsequent biological function analysis such as metastatic potential, invasiveness, and drug sensitivity.

The heterogeneity within the tumor is a huge obstacle for CTC detection technology. In addition, the existing CTC separation technology still has problems such as selection of biomarkers, high separation difficulty, complicated separation technology, and difficulty in ensuring specificity and recovery rate at the same time.

Images